This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, Université Grenoble Alpes, Université´ D'aix-Marseille. Active years: 2022.
Company Filing History:
1 out of 8,807 
1 out of 177 
1 out of 236 
Years Active: 2022
Title: The Innovative Contributions of Patrice Vanelle
Introduction
Patrice Vanelle is a notable inventor based in Marseille, France. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the development of heterocyclic naphthoquinones derivatives, which have potential applications in treating various cancers, including Cushing disease.
Latest Patents
Patrice Vanelle holds 1 patent for his invention titled "Heterocyclic naphthoquinones derivatives for use in the treatment of cancers including Cushing disease." This patent addresses the use of these derivatives in inhibiting Ubiquitin Specific Proteases (USP) 8 and/or 2, which play a crucial role in cancer progression.
Career Highlights
Throughout his career, Vanelle has been associated with prestigious institutions such as Université d'Aix-Marseille and the Commissariat à l'énergie atomique et aux énergies alternatives. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Patrice Vanelle has collaborated with esteemed colleagues, including Vincent Remusat and Marie-Odile Fauvarque. These partnerships have enriched his research and fostered innovation in the field of cancer treatment.
Conclusion
Patrice Vanelle's contributions to cancer research through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to inspire future innovations in the treatment of complex diseases.